Clinical Trial Update: Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on initial treatment for acute bacterial skin and skin-structure infections caused by Staphylococcus aureus (MSSA or MRSA); the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Snippet

Sponsor: PolyMedix, Inc. | Conditions: Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA), (Susceptible or Methicillin Resistant) | Phase 2 | Status: COMPLETED